nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Mitomycin—urinary bladder cancer	0.224	0.379	CbGbCtD
Posaconazole—CYP3A4—Thiotepa—urinary bladder cancer	0.102	0.172	CbGbCtD
Posaconazole—ABCB1—Gemcitabine—urinary bladder cancer	0.0644	0.109	CbGbCtD
Posaconazole—ABCB1—Cisplatin—urinary bladder cancer	0.0468	0.0792	CbGbCtD
Posaconazole—ABCB1—Etoposide—urinary bladder cancer	0.0459	0.0778	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—urinary bladder cancer	0.0313	0.0531	CbGbCtD
Posaconazole—ABCB1—Methotrexate—urinary bladder cancer	0.0304	0.0514	CbGbCtD
Posaconazole—CYP3A4—Etoposide—urinary bladder cancer	0.0275	0.0466	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.0188	0.0318	CbGbCtD
Posaconazole—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000116	0.000284	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000116	0.000283	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—urinary bladder cancer	0.000116	0.000282	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000116	0.000282	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000115	0.000282	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000115	0.00028	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000114	0.000279	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—urinary bladder cancer	0.000114	0.000279	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—urinary bladder cancer	0.000114	0.000278	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000114	0.000277	CcSEcCtD
Posaconazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000114	0.000277	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000113	0.000277	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000113	0.000276	CcSEcCtD
Posaconazole—Chills—Methotrexate—urinary bladder cancer	0.000113	0.000275	CcSEcCtD
Posaconazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000111	0.000272	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000111	0.000272	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—urinary bladder cancer	0.000111	0.000271	CcSEcCtD
Posaconazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000111	0.000271	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000111	0.000271	CcSEcCtD
Posaconazole—Mental disorder—Methotrexate—urinary bladder cancer	0.00011	0.000269	CcSEcCtD
Posaconazole—Rash—Gemcitabine—urinary bladder cancer	0.00011	0.000269	CcSEcCtD
Posaconazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.00011	0.000269	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—urinary bladder cancer	0.00011	0.000268	CcSEcCtD
Posaconazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.00011	0.000268	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—urinary bladder cancer	0.00011	0.000268	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Erythema—Methotrexate—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Headache—Gemcitabine—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Flushing—Epirubicin—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000109	0.000267	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—urinary bladder cancer	0.000109	0.000266	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000109	0.000266	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—urinary bladder cancer	0.000109	0.000266	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000108	0.000264	CcSEcCtD
Posaconazole—Rash—Fluorouracil—urinary bladder cancer	0.000108	0.000264	CcSEcCtD
Posaconazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000108	0.000264	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000108	0.000264	CcSEcCtD
Posaconazole—Headache—Fluorouracil—urinary bladder cancer	0.000108	0.000263	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000108	0.000263	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000107	0.000262	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000107	0.000262	CcSEcCtD
Posaconazole—Asthenia—Etoposide—urinary bladder cancer	0.000107	0.000261	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000107	0.000261	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—urinary bladder cancer	0.000107	0.000261	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000107	0.000261	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000106	0.000259	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000106	0.000259	CcSEcCtD
Posaconazole—Back pain—Methotrexate—urinary bladder cancer	0.000106	0.000258	CcSEcCtD
Posaconazole—Chills—Epirubicin—urinary bladder cancer	0.000106	0.000258	CcSEcCtD
Posaconazole—Pruritus—Etoposide—urinary bladder cancer	0.000106	0.000258	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—urinary bladder cancer	0.000105	0.000257	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—urinary bladder cancer	0.000104	0.000254	CcSEcCtD
Posaconazole—Nausea—Gemcitabine—urinary bladder cancer	0.000104	0.000253	CcSEcCtD
Posaconazole—Vomiting—Cisplatin—urinary bladder cancer	0.000104	0.000253	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—urinary bladder cancer	0.000103	0.000252	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—urinary bladder cancer	0.000103	0.000252	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000103	0.000251	CcSEcCtD
Posaconazole—Rash—Cisplatin—urinary bladder cancer	0.000103	0.000251	CcSEcCtD
Posaconazole—Dermatitis—Cisplatin—urinary bladder cancer	0.000103	0.00025	CcSEcCtD
Posaconazole—Erythema—Epirubicin—urinary bladder cancer	0.000102	0.00025	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—urinary bladder cancer	0.000102	0.00025	CcSEcCtD
Posaconazole—Diarrhoea—Etoposide—urinary bladder cancer	0.000102	0.000249	CcSEcCtD
Posaconazole—Nausea—Fluorouracil—urinary bladder cancer	0.000102	0.000249	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—urinary bladder cancer	0.000102	0.000248	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000102	0.000248	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—urinary bladder cancer	0.000102	0.000248	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—urinary bladder cancer	0.000101	0.000247	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—urinary bladder cancer	0.000101	0.000247	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000101	0.000247	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—urinary bladder cancer	0.000101	0.000246	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—urinary bladder cancer	0.0001	0.000245	CcSEcCtD
Posaconazole—Back pain—Epirubicin—urinary bladder cancer	9.91e-05	0.000242	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—urinary bladder cancer	9.88e-05	0.000241	CcSEcCtD
Posaconazole—Malaise—Methotrexate—urinary bladder cancer	9.87e-05	0.000241	CcSEcCtD
Posaconazole—Dizziness—Etoposide—urinary bladder cancer	9.87e-05	0.000241	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—urinary bladder cancer	9.85e-05	0.00024	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—urinary bladder cancer	9.84e-05	0.00024	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—urinary bladder cancer	9.84e-05	0.00024	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	9.82e-05	0.00024	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—urinary bladder cancer	9.8e-05	0.000239	CcSEcCtD
Posaconazole—Chills—Doxorubicin—urinary bladder cancer	9.77e-05	0.000239	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—urinary bladder cancer	9.73e-05	0.000237	CcSEcCtD
Posaconazole—Nausea—Cisplatin—urinary bladder cancer	9.67e-05	0.000236	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—urinary bladder cancer	9.66e-05	0.000236	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—urinary bladder cancer	9.62e-05	0.000235	CcSEcCtD
Posaconazole—Cough—Methotrexate—urinary bladder cancer	9.56e-05	0.000233	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—urinary bladder cancer	9.54e-05	0.000233	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	9.51e-05	0.000232	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—urinary bladder cancer	9.49e-05	0.000232	CcSEcCtD
Posaconazole—Vomiting—Etoposide—urinary bladder cancer	9.49e-05	0.000232	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—urinary bladder cancer	9.48e-05	0.000231	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—urinary bladder cancer	9.48e-05	0.000231	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—urinary bladder cancer	9.47e-05	0.000231	CcSEcCtD
Posaconazole—Agitation—Epirubicin—urinary bladder cancer	9.42e-05	0.00023	CcSEcCtD
Posaconazole—Rash—Etoposide—urinary bladder cancer	9.41e-05	0.00023	CcSEcCtD
Posaconazole—Dermatitis—Etoposide—urinary bladder cancer	9.4e-05	0.000229	CcSEcCtD
Posaconazole—Headache—Etoposide—urinary bladder cancer	9.35e-05	0.000228	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—urinary bladder cancer	9.34e-05	0.000228	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—urinary bladder cancer	9.32e-05	0.000228	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—urinary bladder cancer	9.32e-05	0.000228	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—urinary bladder cancer	9.32e-05	0.000228	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—urinary bladder cancer	9.28e-05	0.000227	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	9.26e-05	0.000226	CcSEcCtD
Posaconazole—Malaise—Epirubicin—urinary bladder cancer	9.24e-05	0.000226	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—urinary bladder cancer	9.21e-05	0.000225	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—urinary bladder cancer	9.21e-05	0.000225	CcSEcCtD
Posaconazole—Syncope—Epirubicin—urinary bladder cancer	9.19e-05	0.000224	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—urinary bladder cancer	9.17e-05	0.000224	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—urinary bladder cancer	9.17e-05	0.000224	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—urinary bladder cancer	9.12e-05	0.000222	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—urinary bladder cancer	9.01e-05	0.00022	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—urinary bladder cancer	9.01e-05	0.00022	CcSEcCtD
Posaconazole—Cough—Epirubicin—urinary bladder cancer	8.94e-05	0.000218	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—urinary bladder cancer	8.94e-05	0.000218	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—urinary bladder cancer	8.88e-05	0.000217	CcSEcCtD
Posaconazole—Infection—Methotrexate—urinary bladder cancer	8.88e-05	0.000217	CcSEcCtD
Posaconazole—Nausea—Etoposide—urinary bladder cancer	8.86e-05	0.000216	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—urinary bladder cancer	8.85e-05	0.000216	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	8.8e-05	0.000215	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—urinary bladder cancer	8.76e-05	0.000214	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—urinary bladder cancer	8.76e-05	0.000214	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	8.75e-05	0.000214	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—urinary bladder cancer	8.72e-05	0.000213	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—urinary bladder cancer	8.72e-05	0.000213	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—urinary bladder cancer	8.72e-05	0.000213	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—urinary bladder cancer	8.71e-05	0.000213	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—urinary bladder cancer	8.69e-05	0.000212	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—urinary bladder cancer	8.68e-05	0.000212	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	8.66e-05	0.000211	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.64e-05	0.000211	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—urinary bladder cancer	8.62e-05	0.00021	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—urinary bladder cancer	8.55e-05	0.000209	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—urinary bladder cancer	8.53e-05	0.000208	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—urinary bladder cancer	8.52e-05	0.000208	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—urinary bladder cancer	8.52e-05	0.000208	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—urinary bladder cancer	8.5e-05	0.000208	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—urinary bladder cancer	8.49e-05	0.000207	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—urinary bladder cancer	8.43e-05	0.000206	CcSEcCtD
Posaconazole—Oedema—Epirubicin—urinary bladder cancer	8.36e-05	0.000204	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—urinary bladder cancer	8.35e-05	0.000204	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—urinary bladder cancer	8.33e-05	0.000203	CcSEcCtD
Posaconazole—Infection—Epirubicin—urinary bladder cancer	8.31e-05	0.000203	CcSEcCtD
Posaconazole—Cough—Doxorubicin—urinary bladder cancer	8.27e-05	0.000202	CcSEcCtD
Posaconazole—Shock—Epirubicin—urinary bladder cancer	8.23e-05	0.000201	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—urinary bladder cancer	8.21e-05	0.0002	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—urinary bladder cancer	8.2e-05	0.0002	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	8.19e-05	0.0002	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—urinary bladder cancer	8.19e-05	0.0002	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—urinary bladder cancer	8.16e-05	0.000199	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.14e-05	0.000199	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—urinary bladder cancer	8.12e-05	0.000198	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—urinary bladder cancer	8.08e-05	0.000197	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—urinary bladder cancer	8.08e-05	0.000197	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—urinary bladder cancer	8.07e-05	0.000197	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—urinary bladder cancer	8.07e-05	0.000197	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—urinary bladder cancer	8.07e-05	0.000197	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—urinary bladder cancer	8.04e-05	0.000196	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—urinary bladder cancer	8.02e-05	0.000196	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	8.02e-05	0.000196	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—urinary bladder cancer	7.98e-05	0.000195	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—urinary bladder cancer	7.97e-05	0.000195	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—urinary bladder cancer	7.97e-05	0.000194	CcSEcCtD
Posaconazole—Somnolence—Methotrexate—urinary bladder cancer	7.94e-05	0.000194	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—urinary bladder cancer	7.89e-05	0.000193	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—urinary bladder cancer	7.87e-05	0.000192	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—urinary bladder cancer	7.81e-05	0.000191	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—urinary bladder cancer	7.8e-05	0.00019	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—urinary bladder cancer	7.77e-05	0.00019	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—urinary bladder cancer	7.74e-05	0.000189	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	7.72e-05	0.000188	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—urinary bladder cancer	7.7e-05	0.000188	CcSEcCtD
Posaconazole—Infection—Doxorubicin—urinary bladder cancer	7.69e-05	0.000188	CcSEcCtD
Posaconazole—Pain—Methotrexate—urinary bladder cancer	7.64e-05	0.000187	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.62e-05	0.000186	CcSEcCtD
Posaconazole—Shock—Doxorubicin—urinary bladder cancer	7.61e-05	0.000186	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	7.59e-05	0.000185	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	7.58e-05	0.000185	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—urinary bladder cancer	7.56e-05	0.000185	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—urinary bladder cancer	7.55e-05	0.000184	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—urinary bladder cancer	7.52e-05	0.000183	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—urinary bladder cancer	7.51e-05	0.000183	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	7.48e-05	0.000183	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—urinary bladder cancer	7.46e-05	0.000182	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—urinary bladder cancer	7.43e-05	0.000181	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—urinary bladder cancer	7.38e-05	0.00018	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—urinary bladder cancer	7.36e-05	0.00018	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—urinary bladder cancer	7.36e-05	0.00018	CcSEcCtD
Posaconazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.31e-05	0.000178	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—urinary bladder cancer	7.27e-05	0.000177	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—urinary bladder cancer	7.23e-05	0.000176	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.22e-05	0.000176	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—urinary bladder cancer	7.21e-05	0.000176	CcSEcCtD
Posaconazole—Pain—Epirubicin—urinary bladder cancer	7.15e-05	0.000175	CcSEcCtD
Posaconazole—Constipation—Epirubicin—urinary bladder cancer	7.15e-05	0.000175	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—urinary bladder cancer	7.1e-05	0.000173	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—urinary bladder cancer	7.06e-05	0.000172	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—urinary bladder cancer	7.06e-05	0.000172	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.05e-05	0.000172	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—urinary bladder cancer	7e-05	0.000171	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—urinary bladder cancer	6.95e-05	0.00017	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—urinary bladder cancer	6.9e-05	0.000168	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—urinary bladder cancer	6.89e-05	0.000168	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—urinary bladder cancer	6.88e-05	0.000168	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.84e-05	0.000167	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—urinary bladder cancer	6.81e-05	0.000166	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—urinary bladder cancer	6.73e-05	0.000164	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	6.68e-05	0.000163	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—urinary bladder cancer	6.67e-05	0.000163	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—urinary bladder cancer	6.64e-05	0.000162	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—urinary bladder cancer	6.62e-05	0.000161	CcSEcCtD
Posaconazole—Pain—Doxorubicin—urinary bladder cancer	6.62e-05	0.000161	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—urinary bladder cancer	6.61e-05	0.000161	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—urinary bladder cancer	6.61e-05	0.000161	CcSEcCtD
Posaconazole—Hypersensitivity—Methotrexate—urinary bladder cancer	6.58e-05	0.000161	CcSEcCtD
Posaconazole—Asthenia—Methotrexate—urinary bladder cancer	6.41e-05	0.000156	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	6.38e-05	0.000156	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.33e-05	0.000154	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—urinary bladder cancer	6.32e-05	0.000154	CcSEcCtD
Posaconazole—Hypersensitivity—Epirubicin—urinary bladder cancer	6.16e-05	0.00015	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—urinary bladder cancer	6.15e-05	0.00015	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—urinary bladder cancer	6.12e-05	0.000149	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—urinary bladder cancer	6.12e-05	0.000149	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—urinary bladder cancer	6.11e-05	0.000149	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—urinary bladder cancer	6e-05	0.000146	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—urinary bladder cancer	5.92e-05	0.000144	CcSEcCtD
Posaconazole—Dizziness—Methotrexate—urinary bladder cancer	5.91e-05	0.000144	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—urinary bladder cancer	5.72e-05	0.00014	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.7e-05	0.000139	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—urinary bladder cancer	5.68e-05	0.000139	CcSEcCtD
Posaconazole—Rash—Methotrexate—urinary bladder cancer	5.63e-05	0.000138	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—urinary bladder cancer	5.63e-05	0.000137	CcSEcCtD
Posaconazole—Headache—Methotrexate—urinary bladder cancer	5.6e-05	0.000137	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—urinary bladder cancer	5.55e-05	0.000135	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—urinary bladder cancer	5.53e-05	0.000135	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—urinary bladder cancer	5.47e-05	0.000134	CcSEcCtD
Posaconazole—Vomiting—Epirubicin—urinary bladder cancer	5.32e-05	0.00013	CcSEcCtD
Posaconazole—Nausea—Methotrexate—urinary bladder cancer	5.31e-05	0.00013	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—urinary bladder cancer	5.29e-05	0.000129	CcSEcCtD
Posaconazole—Rash—Epirubicin—urinary bladder cancer	5.27e-05	0.000129	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—urinary bladder cancer	5.27e-05	0.000129	CcSEcCtD
Posaconazole—Headache—Epirubicin—urinary bladder cancer	5.24e-05	0.000128	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—urinary bladder cancer	5.12e-05	0.000125	CcSEcCtD
Posaconazole—Nausea—Epirubicin—urinary bladder cancer	4.97e-05	0.000121	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—urinary bladder cancer	4.92e-05	0.00012	CcSEcCtD
Posaconazole—Rash—Doxorubicin—urinary bladder cancer	4.88e-05	0.000119	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—urinary bladder cancer	4.87e-05	0.000119	CcSEcCtD
Posaconazole—Headache—Doxorubicin—urinary bladder cancer	4.85e-05	0.000118	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—urinary bladder cancer	4.6e-05	0.000112	CcSEcCtD
